Skip to main content
Sino Medical Sciences Technology Inc. logo

Sino Medical Sciences Technology Inc. — Investor Relations & Filings

Ticker · 688108 ISIN · CNE100003NY2 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 812 across all filing types
Latest filing 2025-11-28 Governance Information
Country CN China
Listing Shanghai Stock Exchange 688108

About Sino Medical Sciences Technology Inc.

https://www.sinomed.com/

Sino Medical Sciences Technology Inc. (SINOMED) specializes in the research, development, and manufacturing of high-end interventional medical devices. The company focuses on cardiovascular, neurovascular, and structural heart disease treatments. Its core product portfolio includes drug-eluting stents (DES) and balloon catheters, notably the BuMA and BuMA Supreme series. SINOMED utilizes proprietary technologies, such as the eG™ coating, to improve clinical outcomes and patient safety. The company maintains a strong commitment to clinical research and international expansion, aiming to provide innovative solutions for minimally invasive procedures.

Recent filings

Filing Released Lang Actions
赛诺医疗科学技术股份有限公司关于增加注册资本并修改《公司章程》的公告
Governance Information Classification · 95% confidence The document is a detailed announcement from a company named 赛诺医疗科学技术股份有限公司 regarding changes to its business scope and amendments to its Articles of Association (公司章程). It includes extensive legal and regulatory references, detailed modifications to corporate governance documents, capital changes, and shareholder rights. The content is focused on corporate governance, company bylaws, shareholder meetings, and structural changes to the company’s charter rather than financial results or audit opinions. There is no indication that this is an annual report, earnings release, audit report, or any other financial statement. Instead, it is a formal announcement about changes to the company’s governance documents and operational scope, which aligns with the category of Governance Information (CGR). The document is lengthy and substantive, not a brief announcement or a report publication notice, so it is not RPA or RNS. Therefore, the best classification is Governance Information (CGR).
2025-11-28 Chinese
赛诺医疗科学技术股份有限公司防范控股股东及其他关联方资金占用管理制度
Governance Information Classification · 95% confidence The document is a detailed internal policy titled '防范控股股东及其他关联方资金占用管理制度' (Prevention and Control of Funds Occupied by Controlling Shareholders and Other Related Parties) issued by 赛诺医疗科学技术股份有限公司. It outlines principles, responsibilities, and procedures to prevent misuse of company funds by controlling shareholders and related parties. The content is regulatory and governance-focused, detailing internal controls, board responsibilities, audit committee roles, and legal compliance. It does not contain financial statements, earnings data, or audit opinions. It is not an announcement or a brief notice but a comprehensive governance document. Therefore, it fits best under Governance Information (CGR), which covers reports detailing the company's internal rules, board structure, and governance practices.
2025-11-28 Chinese
赛诺医疗科学技术股份有限公司关于取消监事会暨废止监事会议事规则的公告
Board/Management Information Classification · 100% confidence The document is an official announcement from the company about the cancellation of the Supervisory Board and the abolition of the Supervisory Board Rules. It discusses governance changes and the legal basis for these changes, including the impact on current supervisors and the need for shareholder approval. There is no financial data, no report attached or referenced as being published, and no mention of earnings, audits, or other financial results. The content focuses on a change in the company's governance structure, specifically the board and supervisory roles. Therefore, this fits best under Board/Management Information (MANG), which covers announcements of changes in the company's board or senior management structure.
2025-11-28 Chinese
赛诺医疗科学技术股份有限公司内幕信息知情人登记管理制度
Governance Information Classification · 95% confidence The document is a detailed internal management system for insider information registration and confidentiality for a listed company, including definitions, responsibilities, procedures for insider information management, and related legal compliance. It includes detailed rules on insider information, insider registration, confidentiality obligations, and reporting to regulatory bodies. There are no financial statements, earnings data, or investor presentations. It is not an announcement or a brief notice but a comprehensive governance document related to insider information management and compliance with securities laws. This fits the category of Governance Information (CGR), which covers internal rules, board structure, and governance practices.
2025-11-28 Chinese
赛诺医疗科学技术股份有限公司关联交易管理制度
Governance Information Classification · 95% confidence The document is titled '赛诺医疗科学技术股份有限公司 关联交易管理制度' which translates to 'Sino Medical Science and Technology Co., Ltd. Related Party Transaction Management System'. It is a detailed internal policy document outlining the management, definitions, procedures, and pricing principles for related party transactions within the company. It references compliance with laws and stock exchange rules, but it is not a financial report, earnings release, or announcement. It is a governance-related document detailing internal rules and procedures for related party transactions, which fits the Governance Information (CGR) category. The document length is 8120 characters, indicating it is a full policy document rather than a brief announcement or summary. Therefore, the appropriate classification is Governance Information (CGR).
2025-11-28 Chinese
赛诺医疗科学技术股份有限公司对外投资管理制度
Governance Information Classification · 95% confidence The document is titled as an external investment management system of a company, detailing internal policies, organizational structure, approval authorities, management, transfer and recovery of investments, and responsibilities. It is a regulatory or governance document outlining company procedures and compliance with laws and listing rules. There are no financial statements, no earnings data, no audit opinions, no voting results, no call transcripts, no presentations, no announcements of dividends or capital changes, and no merger or acquisition details. The document is a formal internal policy or governance framework related to investment management. Therefore, it fits best under Governance Information (CGR). The document length is over 5,000 characters and contains substantive content, so it is not a mere announcement or regulatory filing. Hence, the classification is CGR with high confidence.
2025-11-28 Chinese

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.